Total Payments
$6,005
2024 Payments
$516.42
Companies
48
Transactions
406
Medicare Patients
4,154
Medicare Billing
$614,004
Payment Breakdown by Category
Food & Beverage$5,937 (98.9%)
Education$68.10 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,937 | 401 | 98.9% |
| Education | $68.10 | 5 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,574 | 134 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $468.06 | 31 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $456.79 | 24 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $384.55 | 23 | $0 (2024) |
| Amarin Pharma Inc. | $311.43 | 16 | $0 (2021) |
| Neos Therapeutics, LP | $249.87 | 14 | $0 (2020) |
| Allergan, Inc. | $218.79 | 23 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $189.22 | 11 | $0 (2024) |
| GlaxoSmithKline, LLC. | $186.66 | 12 | $0 (2024) |
| PFIZER INC. | $181.08 | 11 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $516.42 | 36 | ABBVIE INC. ($208.31) |
| 2023 | $792.17 | 52 | ABBVIE INC. ($341.26) |
| 2022 | $849.41 | 61 | ABBVIE INC. ($384.20) |
| 2021 | $1,107 | 85 | AbbVie Inc. ($370.92) |
| 2020 | $811.64 | 59 | Allergan, Inc. ($164.34) |
| 2019 | $426.25 | 28 | AbbVie, Inc. ($61.69) |
| 2018 | $755.59 | 42 | AstraZeneca Pharmaceuticals LP ($115.98) |
| 2017 | $746.53 | 43 | Neos Therapeutics, LP ($106.03) |
All Payment Transactions
406 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: RESPIRATORY | ||||||
| 11/13/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.63 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: Respiratory | ||||||
| 10/29/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.44 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $4.64 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $14.99 | General |
| Category: NEUROLOGY | ||||||
| 09/05/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: Diabetes | ||||||
| 09/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: DIABETES | ||||||
| 08/29/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: Respiratory | ||||||
| 08/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $4.85 | General |
| Category: NEUROSCIENCE | ||||||
| 08/07/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $26.19 | General |
| Category: NEUROLOGY | ||||||
| 07/16/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: NEUROSCIENCE | ||||||
| 07/10/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: NEUROSCIENCE | ||||||
| 06/27/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: IMMUNOLOGY | ||||||
| 06/27/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $2.57 | General |
| Category: IMMUNOLOGY | ||||||
| 06/18/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: NEUROSCIENCE | ||||||
| 06/06/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: NEUROSCIENCE | ||||||
| 06/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Respiratory | ||||||
| 05/29/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: Oncology | ||||||
| 05/28/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $6.36 | General |
| Category: NEUROSCIENCE | ||||||
| 04/04/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: Obesity | ||||||
| 04/02/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $27.49 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 939 | 1,622 | $240,353 | $134,273 |
| 2022 | 14 | 1,016 | 1,946 | $270,861 | $148,696 |
| 2021 | 14 | 1,032 | 1,917 | $278,400 | $161,785 |
| 2020 | 16 | 1,167 | 2,243 | $300,524 | $169,251 |
Total Patients
4,154
Total Services
7,728
Medicare Billing
$614,004
Procedure Codes
57
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3490 | Unclassified drugs | Office | 2023 | 33 | 108 | $118,800 | $70,444 | 59.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 149 | 333 | $46,440 | $26,538 | 57.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 119 | 119 | $17,850 | $14,362 | 80.5% |
| 11980 | Placement of hormone pellet under skin | Office | 2023 | 33 | 108 | $16,865 | $7,539 | 44.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 49 | 130 | $17,925 | $7,529 | 42.0% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 136 | 146 | $8,030 | $2,478 | 30.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 12 | 12 | $2,100 | $1,865 | 88.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 134 | 142 | $6,390 | $1,060 | 16.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 41 | 88 | $2,200 | $728.70 | 33.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 34 | 99 | $495.00 | $485.10 | 98.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 124 | 138 | $828.00 | $470.58 | 56.8% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 37 | 111 | $1,110 | $389.58 | 35.1% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 38 | 88 | $1,320 | $383.93 | 29.1% |
| J3490 | Unclassified drugs | Office | 2022 | 36 | 165 | $139,500 | $82,658 | 59.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 154 | 340 | $49,249 | $24,903 | 50.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 116 | 116 | $17,400 | $14,386 | 82.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 60 | 157 | $21,730 | $9,091 | 41.8% |
| 11980 | Placement of hormone pellet under skin | Office | 2022 | 36 | 119 | $17,255 | $8,407 | 48.7% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 136 | 148 | $8,140 | $2,651 | 32.6% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 11 | 11 | $1,925 | $1,762 | 91.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 53 | 144 | $3,552 | $1,319 | 37.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 135 | 141 | $6,345 | $1,119 | 17.6% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2022 | 49 | 204 | $2,040 | $915.54 | 44.9% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2022 | 49 | 146 | $2,190 | $640.09 | 29.2% |
| 81002 | Urinalysis, manual test | Office | 2022 | 126 | 135 | $810.00 | $463.90 | 57.3% |
About Dr. Billy May, MD
Dr. Billy May, MD is a Family Medicine healthcare provider based in Baton Rouge, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/26/2005. The National Provider Identifier (NPI) number assigned to this provider is 1215927710.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Billy May, MD has received a total of $6,005 in payments from pharmaceutical and medical device companies, with $516.42 received in 2024. These payments were reported across 406 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($5,937).
As a Medicare-enrolled provider, May has provided services to 4,154 Medicare beneficiaries, totaling 7,728 services with total Medicare billing of $614,004. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Baton Rouge, LA
- Active Since 10/26/2005
- Last Updated 07/24/2019
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1215927710
Products in Payments
- UBRELVY (Drug) $617.18
- CYCLOSET (Drug) $475.43
- Vascepa (Drug) $311.43
- TRINTELLIX (Drug) $302.70
- SYNTHROID (Drug) $302.07
- QULIPTA (Drug) $271.53
- FARXIGA (Drug) $265.81
- Adzenys XR-ODT (Drug) $263.33
- VRAYLAR (Drug) $221.83
- JARDIANCE (Drug) $217.52
- Trintellix (Drug) $211.90
- TRELEGY ELLIPTA (Drug) $174.14
- Synthroid (Drug) $166.41
- UNITHROID (Drug) $140.94
- LINZESS (Drug) $110.80
- VYVANSE (Drug) $105.85
- CHANTIX (Drug) $85.70
- TOUJEO (Drug) $76.70
- NOCDURNA (Drug) $62.32
- FREESTYLE LIBRE 3 (Device) $58.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Baton Rouge
Dr. Susan Julius, Md, MD
Family Medicine — Payments: $177,846
Family Medicine $177,846
Dr. Christine Smith, Md, MD
Family Medicine — Payments: $104,714
Family Medicine $104,714
Myles Jaynes, D.o, D.O
Family Medicine — Payments: $18,709
Family Medicine $18,709
Dr. Gerald Barber, M.d, M.D
Family Medicine — Payments: $18,510
Family Medicine $18,510
Dr. Stan Mays, M.d, M.D
Family Medicine — Payments: $17,123
Family Medicine $17,123
Dr. Yushen Lee, M.d, M.D
Family Medicine — Payments: $16,906
Family Medicine $16,906